Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$191.51 - $216.16 $102 Million - $115 Million
530,645 Added 102.05%
1,050,645 $223 Million
Q2 2023

Aug 14, 2023

BUY
$187.64 - $206.25 $97.6 Million - $107 Million
520,000 New
520,000 $100 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track P Squared Asset Management Ag Portfolio

Follow P Squared Asset Management Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of P Squared Asset Management Ag, based on Form 13F filings with the SEC.

News

Stay updated on P Squared Asset Management Ag with notifications on news.